title: Identification of in vivo phosphorylation sites on human deoxycytidine kinase. Role of Ser-74 in the control of enzyme activity.
abstract: Deoxycytidine kinase (dCK) catalyzes the rate-limiting step of the deoxyribonucleoside salvage pathway in mammalian cells and plays a key role in the activation of numerous nucleoside analogues used in anti-cancer and antiviral chemotherapy. Although compelling evidence indicated that dCK activity might be regulated by phosphorylation/dephosphorylation, direct demonstration was lacking. Here we showed that dCK overexpressed in HEK 293T cells was labeled after incubating the cells with [32P]orthophosphate. Sorbitol, which was reported to decrease dCK activity, also decreased the labeling of dCK. These results indicated that dCK may exist as a phosphoprotein in vivo and that its activity can be correlated with its phosphorylation level. After purification of 32P-labeled dCK, digestion by trypsin, and analysis of the radioactive peptides by tandem mass spectrometry, the following four in vivo phosphorylation sites were identified: Thr-3, Ser-11, Ser-15, and Ser-74, the latter being the major phosphorylation site. Site-directed mutagenesis and use of an anti-phospho-Ser-74 antibody demonstrated that Ser-74 phosphorylation was crucial for dCK activity in HEK 293T cells, whereas phosphorylation of other identified sites did not seem essential. Phosphorylation of Ser-74 was also detected on endogenous dCK in leukemic cells, in which the Ser-74 phosphorylation state was increased by agents that enhanced dCK activity. Our study provided direct evidence that dCK activity can be controlled by phosphorylation in intact cells and highlights the importance of Ser-74 for dCK activity.
authors.affiliation: Laboratory of Physiological Chemistry and Hormone and Metabolic Research Unit, Christian de Duve Institute of Cellular Pathology, Brussels, Belgium.
authors.forename: Caroline
authors.initials: C
authors.lastname: Smal
authors.forename: Didier
authors.initials: D
authors.lastname: Vertommen
authors.forename: Luc
authors.initials: L
authors.lastname: Bertrand
authors.forename: Sandrine
authors.initials: S
authors.lastname: Ntamashimikiro
authors.forename: Mark H
authors.initials: MH
authors.lastname: Rider
authors.forename: Eric
authors.initials: E
authors.lastname: Van Den Neste
authors.forename: Françoise
authors.initials: F
authors.lastname: Bontemps
mesh_terms: D001665:Binding Sites; D002460:Cell Line; D045744:Cell Line, Tumor; D002851:Chromatography, High Pressure Liquid; D003842:Deoxycytidine Kinase / Q000737:chemistry*; D004591:Electrophoresis, Polyacrylamide Gel; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D015151:Immunoblotting; D013058:Mass Spectrometry; D016297:Mutagenesis, Site-Directed; D009154:Mutation; D010766:Phosphorylation; D010957:Plasmids / Q000378:metabolism; D011485:Protein Binding; D017434:Protein Structure, Tertiary; D011994:Recombinant Proteins / Q000737:chemistry; D012694:Serine / Q000737:chemistry*; D013012:Sorbitol / Q000737:chemistry; D021241:Spectrometry, Mass, Electrospray Ionization
chemical_list: D011994:Recombinant Proteins; D012694:Serine; D013012:Sorbitol; D003842:Deoxycytidine Kinase